Upcoming Events
Log In
Pricing
Free Trial

Pancreatic Cyst Case 5

HIDE
PrevNext

0:00

So this is an 84-year-old male. And I'll show you these images first.

0:10

Was getting abdominal pain.

0:16

It's a little bit choppy on my end,

0:17

which is why I'm scrolling a little bit funny, but I think it's settled down now.

0:20

This is the finding.

0:21

Look at the pancreas. It looks pretty abnormal.

0:28

I'll scroll through it a few times here, just so you can go up and down through it.

0:33

Coronals may help you as well,

0:34

just to get a sense of what's going on in this plane.

0:40

Now, clearly there's ductal dilatation approaching the head and neck

0:45

of the pancreas, or something else going on as well, I think.

0:49

So, 84-year-old male. Pain.

0:51

This is what we see.

0:56

Let's pop up the question to the group. Most likely diagnosis?

1:00

So it could be any number of things,

1:01

but what do we think is the best diagnosis given the appearance?

1:05

Is it Mucinous Cystadenocarcinoma?

1:06

We've seen what that looks like.

1:08

Could this be that?

1:10

Possibly.

1:10

Lymphoepithelial cyst?

1:12

Again, putting that there.

1:14

Talked a little bit about that on the first case.

1:17

Could this just be running the milk, chronic pancreatitis?

1:20

Would you just call this chronic pancreatitis,

1:21

move on to your next case.

1:24

Or option three, Main Duct IPMN with adenocarcinoma.

1:31

Yeah, main IPMN.

1:33

So majority said that

1:35

once lymphoepithelial cyst. You know, what I'll say about Iymphoepithelial cyst is

1:38

I don't think I've ever seen a case of it.

1:40

And what I've seen in literature, they're just sort of simple appearing cyst.

1:42

You're seldom going to call it perspective.

1:45

Like, I suppose there are people out there who really know their lymphoepithelial cyst

1:48

and will call them correctly. But most of us, we're never going to call it correctly.

1:54

So it's always going to be a tough thing to say that

1:55

this is the most likely diagnosis.

1:57

But this is a main duct IPMN with adenocarcinoma.

1:59

And I have to say, I haven't seen too many

2:01

really nice cases of it, at least at our place at Latham.

2:04

And this was a really nice example of it.

2:06

So I wanted to share with the group.

2:08

So what are we really seeing here?

2:10

So I think, as you scroll down,

2:11

the first thing I think most people may notice is the ductal dilatation

2:14

quite pronounced, really parenchymal,

2:16

thinning associated with it and it's quite diffused as well.

2:19

But really as you start to get to the neck

2:21

of the pancreas, it's more than just ductal dilatation.

2:23

If you window it, geez, there's soft tissue components.

2:26

There's something in those ducts.

2:27

And as you come down here, there's more soft tissue.

2:29

More soft tissue. And when you start to see that sort

2:32

of stuff, you got to be worried that there's a tumor inside of it.

2:35

Now, could all that be hemorrhage, proteinaceous debris?

2:38

Yeah, but it just doesn't look like it.

2:39

It looks too nodular, looks too much like soft tissue.

2:42

So I think that would be the best diagnosis in this instance.

2:46

Certainly, doesn't look like a mucinous cystadenocarcinoma

2:48

which is more discrete mass with nodules

2:50

and enhancement associated with some of those nodules.

2:54

And chronic pancreatitis can have ductal dilatation

2:57

but you're going to see calcifications and you're certainly

3:00

not going to see soft tissue components like that

3:01

with chronic pancreatitis.

3:02

You're going to see lots of calcification, ductal dilatation and parenchymal atrophy.

3:07

And you know, this is one of those cases

3:09

that I wanted to share with the group because we happened to be following this

3:13

patient for a while for a variety of reasons.

3:15

If you look back here, this is in 2015. And looks pretty good to me.

3:21

I mean, I wouldn't call anything here.

3:22

At most, I would call maybe something here and maybe call a side branch IPMN at most

3:27

over there. Follow it up in a little bit, see what happens over time.

3:31

But over time, two years later,

3:36

started to look like this.

3:39

You start to see ductal dilatation just two years

3:42

And I think the soft tissue components are a little bit tougher

3:45

to see, but knowing that they're there, it's probably going to be this stuff.

3:48

So it's really sort of developing before our eyes.

3:53

And another CT in June of 2020,

3:56

you can start to see the ductal dilatation is even more pronounced.

3:59

And then the most recent CT that we saw was in August of 2020,

4:02

where you can see more ductal dilatation soft tissue components.

4:06

So this turned out to be, as I said, to be a main duct IPMN.

4:09

So if we talk about IPMNs in general,

4:11

these are mucinous producing tumors and they have papillary projections on histology,

4:16

and they're different from mucinous cystadenomas.

4:19

We see them pretty equally in males and females.

4:21

Some people suggest more often seen in males,

4:23

but we see them in all patients and generally in all ages, but tend to be

4:30

more often in the 5th to 7th decade of life.

4:32

But it is variable.

4:34

IPMNs will communicate with a duct.

4:36

Sometimes it's difficult to demonstrate that communication on imaging.

4:39

But if you can, then that's going to be a clue that's going to be an IPMN.

4:43

And all IPMNs will have malignant potential.

4:47

When you sample them, you can have different degrees

4:49

of dysplasia, whether it's low, intermediate or high grade.

4:52

You can have frank invasive carcinoma. And those are true malignancies,

4:57

or the ones when you sample, the pathologists say there's invasive carcinoma

5:01

or that there's high grade dysplasia. Those are the ones we really worry about.

5:05

And as the group probably knows,

5:11

this is...

5:12

They come in a variety of different types on imaging.

5:15

Side branch, main duct, mixed and

5:19

mixed have components both side branch and main duct IPMNs.

5:24

And with a main duct, you're really going

5:25

to see this markedly dilated tortuous duct.

5:28

And you don't really see a discrete obstructing mass,

5:32

but you see these mural nodule associated with it, like you see in this case,

5:36

you're going to be worried that there's an underlying malignancy associated with it.

5:41

If possible, you're going to have to try to resect this.

5:43

This is going to be an impossible

5:45

resection, really, in this instance, given that there's really no much

5:50

pancreatic parechymal associated with the remainder of the pancreas.

5:54

But in general, when you look at IPMNs, when do you want to consider resection?

5:58

Well, when they're associated with ductal

6:00

dilatation that's pronounced more than ten millimetres.

6:02

When you see enhancing nodules, or,

6:05

and, or if you have any symptoms that are attributable to that.

6:07

So symptoms is not something we can necessarily see, but we can see ductal

6:11

dilatation, we can see enhancing nodules just when we get suspicious for it.

6:14

And there were some questions here.

6:18

Somebody asked, is this a main duct that developed from a side branch?

6:21

I always thought main duct developed without side branch proceeding it.

6:23

That's a great question.

6:25

I don't know if this was a main duct that developed from a side branch.

6:30

All I can say is that back in the day, in 2015, I would not have called much

6:35

except for potentially a cystic lesion in sort of the incident process.

6:40

And for all we know,

6:41

this was sort of a budding main duct arising from the ventral duct

6:47

of the pancreas, that then sort of took over and involved everything.

6:51

So I think your comment is well taken.

6:53

Usually, they don't develop in the context of the side-branch IPMN, but then I think this

6:57

probably developed independent of that, as you suggested.

7:00

And somebody also asks, is it possible fracture in main duct IPMN

7:04

with ductal dilatation, simply to an obstruction caused by cancer?

7:07

I always think, this stuff is going to be challenging.

7:09

I think with a cancer, you're just going to see a more discrete

7:13

mass and then upstream from it, the duct will be dilated.

7:16

In this instance, you're not really seeing a discrete mass.

7:19

What you're seeing is the duct that's

7:20

dilated and sort of at the periphery of the duct, there's these soft tissue nodules.

7:25

These soft tissue mural nodules, wall based nodules.

7:28

When you see mural nodules associated

7:31

with ductal dilatation, then you kind of think of a malignant sort

7:33

of transformation of an IPMN. When you see a more discrete mass

7:37

without sort of portions of the duct going through it, then you're going to think

7:41

of an adenocarcinoma that's causing ductal obstruction.

7:44

So I think in this instance, it's probably reasonable to think it's

7:50

an invasive cancer rising in main duct IPMN.

7:53

But I suppose if you didn't have this sort of appearance here,

7:55

where there was appearance of the duct going through and this was all soft

7:58

tissue, perhaps it would be harder to call that perspectively.

8:04

Great questions.

8:08

Hopefully sufficient answers.

8:09

I know it's never...

8:11

Don't have all the answers, but I'm trying my best to hopefully

8:17

satiate your thirst for knowledge and questions that you have.

8:21

And two more cases and we have about seven minutes,

8:24

so let me go through them so we can get through the hour.

Report

Faculty

Mahan Mathur, MD

Associate Professor, Division of Body Imaging; Vice Chair of Education, Dept of Radiology and Biomedical Imaging

Yale School of Medicine

Tags

Pancreas

Other Systems

Oncologic Imaging

Neuroendocrine

Neoplastic

Multidisciplinary considerations

MRI

General Oncologic Imaging Concepts

Gastrointestinal (GI)

CT

Body

© 2024 Medality. All Rights Reserved.

Contact UsTerms of UsePrivacy Policy